Protein drink tested for Post-Workout recovery in healthy adults
NCT ID NCT07497113
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a commercially available high-protein yoghurt drink helps muscles recover after intense exercise. 62 healthy adults aged 18-45 took part. Researchers measured amino acid levels in the blood and markers of muscle damage, inflammation, and physical function over 72 hours. The goal was to see if the drink improves recovery compared to a plain protein drink or flavored water.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- high-protein yoghurt drink
- What this could lead to
- If the results show benefits, it could support using this drink to help muscle recovery after exercise.
- What could go wrong
- This is a small, completed study in healthy people, so findings may not apply to athletes or those with medical conditions. The drink is not a treatment for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
62 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 and ≤ 45 years. * Body Mass Index (BMI) ≥ 18.5 and ≤ 29.9 kg/m2 (measured at the first assessment), * Written informed consent (undertaken at the first assessment). * Willingness and ability to comply with the protocol in the opinion of the investigator. * Judged by the investigator to be in good health as assessed by a health screening questionnaire. * Currently identifies as the same biological sex as at birth. Exclusion Criteria: * Any known ongoing medical condition that might interfere with absorption and digestion and/or gastrointestinal (GI) function (e.g. inflammatory bowel disease, gastroesophageal reflux disease, celiac disease, diaphragmatic hernia or diaphragmatic surgery, gastric ulcer, gastritis, gall bladder problems, pancreatitis, GI cancer, oesophageal and/or gastric surgery).), in opinion of the investigator, * Known musculoskeletal or soft tissue injury. * Known cardiovascular disease, disease related to the immune system and/or the respiratory system. * Known renal or hepatic failure or known thyroid dysfunction. * Known Diabetes Mellitus type I or type II, insulin resistance or metabolic syndrome. * Any ongoing cancer (except for basal cell carcinoma) and/ or cancer treatment, * Known anaemia or low haemoglobin or low iron status. * Any known bleeding disorder or reaction to withdrawal of blood samples. * Use of oral and systemic use of prokinetics, laxatives, antidiarrheals, anticoagulants within 2 weeks prior to screening. * Use of systemic antibiotics within 4 weeks prior to screening. * Any known dietary allergies. * Any known intolerances to ingredients of the study product, i.e. dairy, cow's milk allergies, lactose intolerance. * Self-reported adherence to a strict dietary regime (e.g. vegetarian/ vegan/ paleo/ketogenic/intermittent fasting/ high protein diet (\>1.6 g/kg body weight/day), or protein supplementation or a weight loss program, as confirmed via the screening process. * Use of any nutritional supplements or additional protein supplements or nutritional support within 4 weeks prior to screening. * Engage (on average) in more than 2 resistance exercise sessions and/or more than 4 exercise sessions in total weekly within 2 months before screening, * Considered as endurance trained, competitive athletes or trained weightlifters, powerlifters or bodybuilders, in the opinion of the investigator. * Known pregnancy and/or lactating. * Current smoking or stopped smoking for \<1 month prior to screening (except for incidental smoking of ≤3 cigarettes/cigars/pipes per week on average in the last month). * Average alcohol use of \>21 glasses\* per week for men or \>14 glasses per week for women (on average during the last 6 months) or drug/ medicine abuse in opinion of the investigator. * Participation in any other clinical study with investigational or marketed products concomitantly or within 4 weeks before screening. * Major medical or surgical event requiring hospitalization within the preceding 3 months and/or scheduled in the period of study participation relevant in the opinion of the investigator.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy participants are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anglia Ruskin University
Cambridge, RH14 9YY, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body
- Radioactive tag lets scientists follow an experimental drug through the human body